OTCMKTS:IVITF Invictus MD Strategies (IVITF) Stock Price, News & Analysis → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free IVITF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume4,000 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Invictus MD Strategies alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Invictus MD Strategies Stock (OTCMKTS:IVITF)Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. IVITF Stock News HeadlinesApril 16, 2024 | morningstar.comInvictus MD Strategies Corp Class A IVITFNovember 20, 2023 | forbes.comHagerstown, MDApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.September 9, 2023 | foxnews.comPrince Harry’s ‘Heart of Invictus’ deserves praise, but he must ‘spare’ public from swipes at royals: expertsAugust 3, 2023 | newsweek.com18 Strategies to Approach Business Decisions ObjectivelyJuly 17, 2023 | forbes.comAnnapolis, MDApril 25, 2023 | forbes.comBaltimore, MDApril 22, 2023 | health.usnews.comSinai Hospital of BaltimoreApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 15, 2023 | entrepreneur.com6 Social Media Content Strategies That Will Transform You From An Unknown to a Trusted AuthorityJanuary 28, 2023 | entrepreneur.com10 Business Strategies and Trends to Consider in 2023September 20, 2022 | investing.comInvictus MD Strategies Corp (GENEh)September 15, 2022 | ca.finance.yahoo.comInvictus MD Strategies Corp. (GENE-H.V)June 4, 2022 | benzinga.comInvictus MD Strategies (OTC:IVITF), Earnings Estimates, EPS, and RevenueMarch 28, 2022 | benzinga.comCould A Weed Tolerance Break Help Me Save Money? Budtender Weighs InMarch 27, 2022 | benzinga.comWhy Sundial Growers Shorts Are About To Go Up In SmokeMarch 22, 2022 | benzinga.comParenting Today: How To Talk To Your Kids About MarijuanaMarch 8, 2022 | benzinga.comThe Road To Psychedelics LegalizationMarch 3, 2022 | benzinga.comMedical Marijuana's Kannaway To Launch Its First CBD Product With 1% THC At Its Event In PragueFebruary 25, 2022 | benzinga.comNeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health ClinicJanuary 21, 2022 | benzinga.comCanntab Launches E-Commerce Platform, Enabling Canadians Access To THC & CBD In Pill FormJanuary 21, 2022 | benzinga.comHEXO Updates Strategic Plan: Expects $37.5M Incremental Cash Flow In 2022January 17, 2022 | benzinga.comInvestors Increasingly Seek Cannabis Debt Investment As An Opportunity To DiversifyJanuary 12, 2022 | benzinga.comWeedWeek's' Cannabiz Predictions For 2022January 6, 2022 | benzinga.comPsilocybin Does Not Produce Adverse Effects On Cognition Or Emotional Function, New Study FindsJanuary 2, 2022 | benzinga.comColorado Governor Polis Pardons Over 1300 People For Minor Marijuana CrimesDecember 31, 2021 | benzinga.comIllinois' Cannabis Revenue Outpaces Liquor Taxes By Almost $100M In 2021See More Headlines Receive IVITF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Invictus MD Strategies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:IVITF CUSIPN/A CIK1737647 Webinvictus-md.com Phone(647) 828-9655FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Daniel Stanislav Kriznic CA (Age 45)CPA, Founder and Advisor to Chairman & CEO Comp: $789.96kImran HaiderChief Executive OfficerMr. Marc RipaChief Operating OfficerMs. Brenda Mae DixonChief Science OfficerMr. Larry Heinzlmeir MBAVice President of Marketing & CommunicationsKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors IVITF Stock Analysis - Frequently Asked Questions How do I buy shares of Invictus MD Strategies? Shares of IVITF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IVITF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invictus MD Strategies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
